Data Access

CoDES faculty will help facilitate access to various CoDES Data Sources along with publicly available data from the National Ambulatory Medical Care Survey (NAMCS), Medical Expenditure Panel Survey (MEPS), National Health and Nutrition Examination Survey (NHANES), Healthcare Cost and Utilization Project (HCUP), Medical Information Mart for Intensive Care (MIMIC)-IV). We will also connect new big data researchers with collaborators who are experienced with the use of certain data sets and cohorts.

Data Request

For those interested we ask that you complete a Data Request Form that will serve as a starting point for us to assist you with data access and data analysis.

To help you get started, we included a sample Data Request Form . This form (used with permission) helped generate two research abstracts for Dr. Mohammed Ruzieh (see testimonial below) submitted to the American College of Cardiology Annual Scientific Session & Expo.

If you have any questions regarding “Big Data Access”, please reach out to Core Lead, Scott Vouri (svouri@ufl.edu).


Clinical Assistant Professor of Cardiology, UF Health

Mohammed Ruzieh, M.D.

"I have an interest in outcomes research. A few months after starting my career at UF, I contacted Dr. Almut Winterstein to use Medicare and MarketScan databases for my research. Dr. Winterstein connected me with Dr. Vouri, a faculty member and lead for clinical collaborations within CoDES, and Dr. Nicole Smolinski, a Ph.D. student in their department. Together, we are studying a recently FDA-approved cardiac device. CoDES offers great opportunities for research and collaboration for the following reasons. First, the process for collaboration and getting started on the project is smooth. Second, the department of pharmaceutical outcomes and policy has a long track record of using these databases and will help you with the study design, statistical analysis, etc. Third, access to the databases, including IRB approvals and other regulatory processes are smooth and well organized by the center. Fourth, these database not only have data on patient's diagnosis but also on procedures, health care costs, medications, medication doses, etc., and thus, offer close longitudinal follow-up to evaluate outcomes. Finally, both MarketScan and Medicare databases are considered reliable sources to develop real-world evidence on drug or device outcomes, and you can publish in high-impact journals."

Mohammed Ruzieh